DOSSIER · 13F Holders · Q3 2026
RECURSION PHARMACEUTICALS IN
6 institutions still hold RECURSION PHARMACEUTICALS IN as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 75629V954·6 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q3 2026
6 institutions reported RECURSION PHARMACEUTICALS IN in Q3 2026. NATIONAL BANK OF CANADA /FI/ leads at 47.5% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.